World's Best Scientists 2026 revealed!
Ben A. C. Dijkmans

Ben A. C. Dijkmans

D-Index & Metrics

Medicine

D-Index
110
Citations
51222
World Ranking
5499
National Ranking
207

Ben A. C. Dijkmans publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ben A. C. Dijkmans sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 404 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ben A. C. Dijkmans D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ben A. C. Dijkmans sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 110 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ben A. C. Dijkmans is affiliated with Amsterdam UMC in the Netherlands. This association situates them within a research university medical center environment, likely contributing to clinical or biomedical academic work. The profile presents no data on specific research papers, fields of study, or topics linked to their name.

There are no recorded recent papers, frequent co-authors, or common publication venues associated with Ben A. C. Dijkmans in the available data. Similarly, there is no information on book publications or distinct academic fields, subfields, or main topics of study related to their research.

No awards or honors have been listed, and the available data confirms that Ben A. C. Dijkmans is currently living. The limited information suggests that the profile is focused solely on the professional affiliation without further detail on research output or scientific contributions.

Best Publications

  • The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy

    Dougados M;van der Linden S;Juhlin R;Huitfeldt B

  • Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors

    Markus M. J. Nielen;Dirkjan van Schaardenburg;Henk W. Reesink;Rob J. van de Stadt

  • EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

    M J Peters;D P M Symmons;D McCarey;B A Dijkmans

  • Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

    Y. P. M. Goekoop-Ruiterman;J. K. De Vries-Bouwstra;C. F. Allaart;D. Van Zeben

  • Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

    Maarten Boers;Arco C Verhoeven;Harry M Markusse;Mart Afj van de Laar

  • 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J Braun;R van den Berg;X Baraliakos;H Boehm

  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

    M Rudwaleit;R Landewé;D van der Heijde;J Listing

  • Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

    Désirée van der Heijde;Alan Kivitz;Michael H. Schiff;Joachim Sieper

  • Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

    Désirée van der Heijde;Ben Dijkmans;Piet Geusens;Joachim Sieper

  • ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J. Zochling;D. Van Der Heijde;R. Burgos-Vargas;E. Collantes

  • Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up.

    Geertje M. Bartelds;Charlotte L. M. Krieckaert;Michael T. Nurmohamed;Pauline A. van Schouwenburg

  • COBRA Combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention

    Robert B. M. Landewé;Maarten Boers;Arco C. Verhoeven;Rene Westhovens

  • New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)

    J. Sieper;D.M. Van der Heijde;RB Landewe;J. Brandt

  • Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

    Geertje M Bartelds;Carla A Wijbrandts;Michael T Nurmohamed;Steven Stapel

  • Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis

    Gerrit Jan Wolbink;Marijn Vis;Willem Lems;Alexandre E. Voskuyl

  • Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial.

    Yvonne P M Goekoop-Ruiterman;Jeska K de Vries-Bouwstra;Cornelia F Allaart;Derkjen van Zeben

  • Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein

    Ruud Oerlemans;Niels E. Franke;Yehuda G. Assaraf;Jacqueline Cloos

  • Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission.

    Esmeralda T. H. Molenaar;Alexandre E. Voskuyl;Huib J. Dinant;P. Dick Bezemer

  • Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

    A E van Ede;R F Laan;M J Rood;T W Huizinga

  • Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.

    Mike J. Peters;Irene E. van der Horst-Bruinsma;Ben A. Dijkmans;Michael T. Nurmohamed

Frequent Co-Authors

Willem F. Lems
Willem F. Lems Vrije Universiteit Amsterdam
Michael T. Nurmohamed
Michael T. Nurmohamed University of Amsterdam
Ferdinand C. Breedveld
Ferdinand C. Breedveld Leiden University Medical Center
Jan P. Vandenbroucke
Jan P. Vandenbroucke Leiden University Medical Center
Maarten Boers
Maarten Boers Vrije Universiteit Amsterdam
Gerrit Jansen
Gerrit Jansen Amsterdam UMC
Rik J. Scheper
Rik J. Scheper Amsterdam University Medical Centers
Robert Landewé
Robert Landewé University of Amsterdam
Paul P. Tak
Paul P. Tak GlaxoSmithKline (United Kingdom)
Erik J. Giltay
Erik J. Giltay Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative medical career pathways can provide flexibility, affordability, and quicker access to the healthcare workforce. For those looking to enter nursing rapidly, learning what is the fastest way to become an lpn can be a great starting point. Many choose this path to gain hands-on experience sooner and begin working in patient care.

If you are interested in advanced practice and mental health, there are programs designed for speed and specialization. Discover your options with accelerated msn psychiatric np programs, which can help qualified nurses quickly transition into mental health roles.

Not all careers in medicine require direct patient interaction. You might consider the administrative side by researching healthcare administration degrees. These online programs are ideal for those interested in leadership and management roles within healthcare organizations.

Affordability is a common concern. Understanding mha degree cost can help you make informed decisions regarding your education and manage tuition expenses more effectively.

Best Scientists Citing Ben A. C. Dijkmans

Trending Scientists

Recently Published Articles